Quoin Pharmaceuticals share price logo

Quoin Pharmaceuticals

NASDAQ: QNRX

$6.79

-0.11

(-1.59%)

as on

Quoin Pharmaceuticals Stock Performance

as on September 12, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.66
    $6.82
    downward going graph

    1.91%

    Downside

    0.44%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.25
    $41.80
    downward going graph

    52.14%

    Downside

    515.61%

    Upside

    downward going graph

Quoin Pharmaceuticals share price movements today

Previous Close
$6.90
Open
$6.71
Volume
282.2K
Market Cap
$14.4M
Day's Low - High
$6.66 - $6.82
52 Week Low - High
$3.25 - $41.80

Quoin Pharmaceuticals Historical Returns

1 Month Return
+ 30.04 %
3 Month Return
+ 37.75 %
1 Year Return
-5.94 %
3 Year Return
-96.49 %
5 Year Return
0 %

Quoin Pharmaceuticals Stock Fundamentals & Key Indicators

Check Quoin Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.4M

EPS (TTM)

-14.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.47

Industry PE ratio

-1.62

PEG Ratio

-0.0009477392928483122

EBITDA

-18.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-304.87%

Quoin Pharmaceuticals Stock Valuation

Track how Quoin Pharmaceuticals P/E has moved over time to understand its valuation trends.

Quoin Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-25.68x)

December 31, 2022

Industry (-1.62x)

December 31, 2025

Today (-1.36x)

December 31, 2025

Highest (-0.34x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.36x

Quoin Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Quoin Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$14.4MNA-0.470.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$56.0B-69.82%-16.99-12.57%NA
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Stock Returns calculator for Quoin Pharmaceuticals Stock including INR - Dollar returns

The Quoin Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Quoin Pharmaceuticals investment value today

Current value as on today

₹99,172

Returns

-₹828

(-0.83%)

Returns from Quoin Pharmaceuticals Stock

-₹8,367 (-8.37%)

Dollar Impact

₹7,539 (+7.54%)

Analyst Recommendation on Quoin Pharmaceuticals Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Quoin Pharmaceuticals. Average target price of $22.2

Quoin Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Quoin Pharmaceuticals.

What analysts predicted

69.41%UPSIDE

Target Price

$22.2

Current Price

$6.79

Analyzed by

3 Analysts

Target

$22.20

Quoin Pharmaceuticals target price $22.2, a slight upside of 69.41% compared to current price of $6.79. According to 3 analysts rating.

Indian Investors' Interest in Quoin Pharmaceuticals Stock

Investment in Quoin Pharmaceuticals Shares on INDmoney has grown by 2480.00% in the last 30 days, indicating increased investment activity.

Time period: to

Change:2480.00% versus previous 30 day period

Search interest for Quoin Pharmaceuticals Stock has increased by 287% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:287% versus previous 30 day period

Quoin Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
0
Operating Income
-2
-2
-2
-2
-3
-3
-4
-4
-5
-5
EBITDA
-2
-1
-2
-2
-3
-3
-3
-4
-5
-5
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
-
0
Income Before Tax
-2
-1
-2
-2
-3
-3
-3
-4
-4
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-1
-2
-2
-3
-3
-3
-4
-4
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quoin Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
-
Operating Income
10
15
-1
-1
-6
-9
-9
-9
-16
EBITDA
-7
-5
-1
-1
-20
-8
-8
-8
-15
Interest Expense
-
-
0
1
1
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
10
15
-1
-2
-21
-9
-8
-8
-15
Income Tax Expense
-1
0
-
-
-
-
-
-
-
Net Income
10
15
-1
-2
-21
-9
-8
-8
-15
Net Profit Margin
0.00%
144.90%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Quoin Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-1
-2
-2
-3
-3
-3
-15,793
-4
-5
Operating Cash Flow
-1
-2
-2
-2
-2
-3
-2
-5
-4
-3
Investing Cash Flow
-4
3
2
-3
2
1
2
-11
4
4
Financing Cash Flow
5
0
0
5
0
0
0
18
0
0
Change in Cash
0
1
0
0
0
-2
0
1
0
0

Quoin Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-5
-4
-2
-21
-9
-8
-9
-15
Operating Cash Flow
-4
-6
-5
-1
-5
-8
-7
-7
-13
Investing Cash Flow
2
3
0
0
0
-10
2
-1
-4
Financing Cash Flow
4
3
6
1
13
14
5
10
18
Change in Cash
2
0
0
-4
7
-4
0
1
0

Global Institutional Holdings in Quoin Pharmaceuticals

Funds
Holdings
Michael Rockefeller
3.81%

Quoin Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 28 August

    Fri, 03:35 PM

    -

    Quoin Pharmaceuticals reports positive interim results from Phase 2/3 study of QRX003 for Netherton Syndrome, showing significant efficacy.

    Fri, 03:40 PM

    -

    Quoin Pharmaceuticals announces $50M private placement to fund operations and clinical development of QRX003.

Insights on Quoin Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, QNRX stock has moved up by 12.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 523.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 32.6% return, outperforming this stock by 129.0%

About Quoin Pharmaceuticals

Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
OrganisationQuoin Pharmaceuticals
Headquarters42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
IndustryBiotechnology
CEODr. Michael Myers Ph.D.
E-voting on sharesClick here to vote

Key Management of Quoin Pharmaceuticals

Name

Title

Dr. Michael Myers Ph.D.

Co-Founder, CEO & Chairman

Ms. Denise Carter

Co-Founder, COO & Director

Ms. Sally Lawlor

Chief Financial Officer

FAQs

What is Quoin Pharmaceuticals share price today?

Quoin Pharmaceuticals share price today is $6.79 as on at the close of the market. Quoin Pharmaceuticals share today touched a day high of $6.82 and a low of $6.66.

What is the 52 week high and 52 week low for Quoin Pharmaceuticals share?

Quoin Pharmaceuticals share touched a 52 week high of $41.80 on and a 52 week low of $3.25 on . Quoin Pharmaceuticals stock price today i.e. is closed at $6.79,which is 83.76% down from its 52 week high and 108.92% up from its 52 week low.

What is Quoin Pharmaceuticals's market capitalisation today?

Quoin Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Quoin Pharmaceuticals Stock (QNRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Quoin Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quoin Pharmaceuticals Shares that will get you 0.2209 shares as per Quoin Pharmaceuticals share price of $6.79 per share as on September 12, 2026 at 8:46 am IST.

What is the minimum amount required to buy Quoin Pharmaceuticals Stock (QNRX) from India?

Indian investors can start investing in Quoin Pharmaceuticals (QNRX) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Quoin Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Quoin Pharmaceuticals share’s latest price of $6.79 as on September 12, 2026 at 8:46 am IST, you will get 1.4728 shares of Quoin Pharmaceuticals. Learn more about fractional shares .